Paid Clinical Trials in Madera, CA
As of August 2026, 36 paid clinical trials are recruiting in Madera, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Madera offers studies at sites including Valley Children's Hospital for conditions such as Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome, Ganglioneuroblastoma, Nodular. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Madera
Trials by drug in Madera
Filter results
36 clinical trials
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Project: Every Child for Younger Patients With Cancer
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
I-DECIDE After Bronchiolitis Hospitalization
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Quality of Pediatric Resuscitation in a Multicenter Collaborative
International Rare Histiocytic Disorders Registry (IRHDR)
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Top Research Study Locations in Madera
Researchers run research studies in Madera, CA at 5 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Valley Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 32 |
| Children's Hospital of Orange County | Spinal Muscular Atrophy (SMA) | 1 |
| Lumos Pharma Investigational Site | Growth Hormone Deficiency (GHD) | 1 |
| Madera Family Medical Group | Pneumococcal Infection | 1 |
| Valley Children's Healthcare | Spinal Muscular Atrophy (SMA) | 1 |
Active & Upcoming Studies in Madera (2026)
Recruiting trials in Madera grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
- Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · Phase 2 · National Cancer Institute (NCI)
Cardiovascular (1 active study)
- Quality of Pediatric Resuscitation in a Multicenter Collaborative · Children's Hospital of Philadelphia
Common conditions studied in Madera
- Acute Myeloid Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (2 active studies)
- Down Syndrome (2 active studies)
- Ganglioneuroblastoma, Nodular (2 active studies)
- Malignant Solid Neoplasm (2 active studies)
- Mixed Phenotype Acute Leukemia (2 active studies)
Leading research sponsors in Madera
- Children's Oncology Group
- National Cancer Institute (NCI)
- AstraZeneca
- Catalyst Pharmaceuticals, Inc.
- Children's Hospital of Philadelphia
Frequently asked questions
How many paid clinical trials are currently recruiting in Madera?
There are approximately 36 recruiting clinical trials in Madera, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Madera pay participants?
Most recruiting trials in Madera compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Madera?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Madera?
The most common conditions under active study in Madera include Acute Myeloid Leukemia (3), B Acute Lymphoblastic Leukemia (2), Down Syndrome (2), Ganglioneuroblastoma, Nodular (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Madera?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Madera on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Madera?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Madera?
Recruiting research sites in Madera include Valley Children's Hospital, Children's Hospital of Orange County, Lumos Pharma Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Madera right now?
The largest active categories in Madera are Cancer & tumors (17), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.